Feasibility of a Remotely-Delivered Resistance Training Program for Cognitive Function in Men Living With and Beyond Prostate Cancer
Launched by UNIVERSITY OF TORONTO · Feb 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into whether a remote resistance training program can help improve thinking and memory skills in men who are living with or have survived prostate cancer. Prostate cancer treatments, especially a type called androgen deprivation therapy (ADT), can lead to issues with cognitive function. The researchers want to see if an 8-week exercise program, delivered online, can make a difference for these men, especially since many face challenges like transportation or time that can make getting to a gym difficult.
To participate in this trial, men must be at least 18 years old and have had treatment for localized or certain types of prostate cancer, specifically those who have undergone ADT. They should also have mild cognitive impairment and be largely inactive, meaning they do not get much exercise. Participants will need to have a webcam and internet access to join the program remotely. If you qualify and join, you can expect to engage in guided resistance training exercises from the comfort of your home, helping you improve both your physical strength and cognitive health.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years of age
- • localized or asymptomatic metastatic primary prostate cancer (i.e., androgen receptor axis agents \[ARATs\] including conventional ADT, abiraterone, enzalutamide)
- • a history of ADT treatment
- • not currently undergoing radiation
- • no neurological or musculoskeletal co-morbidity inhibiting exercise
- • mild cognitive impairment as determined by the TICS-M \[scores between 21-24 to separate individuals with mild cognitive impairment and normal cognition (\>24)\]
- • not physically active (self-report \<90 minutes of MVPA/week and \<2 days of RT/week)
- • physician clearance to participate
- • access to a webcam and internet
- • able to complete the study in English.
- Exclusion Criteria:
- • a medical condition that prevents unsupervised exercise
- • presence of other primary or recurrent invasive cancer
- • have experienced a fall in the last 12 months
- • use a gait aid device
- • current participation in other exercise programs/trials
- • colour-blind since the objective cognitive tests require participants to distinguish between colours.
About University Of Toronto
The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported